besides permitting full activation , the use of low ph to destroy critical plasma protease inhibitors allowed the conversion of prekallikrein to kallikrein in as many as 44 plasma samples at one time without the tedious individual timing step usually required to activate each sample .
C0033024
prekallikrein
C0022478
kallikrein